Cargando…

Identification of a novel combination treatment strategy in clear cell renal cell carcinoma stem cells with shikonin and ipilimumab

BACKGROUND: Management of clear cell renal cell carcinoma (ccRCC) has changed rapidly in recent years with the advent of immune checkpoint inhibitors (ICIs). However, only a limited number of patients can sustainably respond to immune checkpoint inhibitors and many patients develop resistance to the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lyu, Chen, Stadlbauer, Birgit, Wang, Lili, Buchner, Alexander, Pohla, Heike
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445237/ https://www.ncbi.nlm.nih.gov/pubmed/37622107 http://dx.doi.org/10.3389/fimmu.2023.1186388

Ejemplares similares

Identification of EZH2 as Cancer Stem Cell Marker in Clear Cell Renal Cell Carcinoma and the Anti-Tumor Effect of Epigallocatechin-3-Gallate (EGCG)
por: Lyu, Chen, et al.
Publicado: (2022)

A Pan-Cancer Landscape of ABCG2 across Human Cancers: Friend or Foe?
por: Lyu, Chen, et al.
Publicado: (2022)

Diagnostic and Prognostic Role of miR-192 in Different Cancers: A Systematic Review and Meta-Analysis
por: Wang, Lili, et al.
Publicado: (2021)

Identification of Ligand-Receptor Pairs Associated With Tumour Characteristics in Clear Cell Renal Cell Carcinoma
por: Liu, Fahui, et al.
Publicado: (2022)

Identification of immunogenic cell death-related signature on prognosis and immunotherapy in kidney renal clear cell carcinoma
por: Jiang, Silin, et al.
Publicado: (2023)

Identification and validation of an immune-related gene prognostic signature for clear cell renal carcinoma
por: Hua, Shan, et al.
Publicado: (2022)

Comparative Effectiveness of Front-Line Ipilimumab and Nivolumab or Axitinib and Pembrolizumab in Metastatic Clear Cell Renal Cell Carcinoma
por: Zarrabi, Kevin K, et al.
Publicado: (2022)

Development of a Phagocytosis-Dependent Gene Signature to Predict Prognosis and Response to Checkpoint Inhibition in Clear-Cell Renal Cell Carcinoma
por: Li, Kunping, et al.
Publicado: (2022)

Shikonin Prolongs Allograft Survival via Induction of CD4(+)FoxP3(+) Regulatory T Cells
por: Zeng, Qiaohuang, et al.
Publicado: (2019)

Identification of a claudin-low subtype in clear cell renal cell carcinoma with implications for the evaluation of clinical outcomes and treatment efficacy
por: Zhang, Cuijian, et al.
Publicado: (2022)

Identification of ST3GAL5 as a prognostic biomarker correlating with CD8(+) T cell exhaustion in clear cell renal cell carcinoma
por: Liu, Jiakuan, et al.
Publicado: (2022)

Serum C-reactive Protein Level Predicts Overall Survival for Clear Cell and Non-Clear Cell Renal Cell Carcinoma Treated with Ipilimumab plus Nivolumab
por: Yano, Yusuke, et al.
Publicado: (2022)

Corrigendum: Development of a phagocytosis- dependent gene signature to predict prognosis and response to checkpoint inhibition in clear-cell renal cell carcinoma
por: Li, Kunping, et al.
Publicado: (2023)

Decoding the Immune Microenvironment of Clear Cell Renal Cell Carcinoma by Single-Cell Profiling to Aid Immunotherapy
por: Liu, Jie, et al.
Publicado: (2022)

Identification and experimental validation of a tumor-infiltrating lymphocytes–related long noncoding RNA signature for prognosis of clear cell renal cell carcinoma
por: Deng, Yulin, et al.
Publicado: (2022)

Identification of epigenetic dysregulation gene markers and immune landscape in kidney renal clear cell carcinoma by comprehensive genomic analysis
por: Xie, Linli, et al.
Publicado: (2022)

Nivolumab plus ipilimumab induced endocrinopathy and acute interstitial nephritis in metastatic sarcomatoid renal-cell carcinoma: A case report and review of literature
por: Hino, Christopher, et al.
Publicado: (2022)

Shikonin derivatives cause apoptosis and cell cycle arrest in human chondrosarcoma cells via death receptors and MAPK regulation
por: Lohberger, Birgit, et al.
Publicado: (2022)

Roles of the Dynamic Tumor Immune Microenvironment in the Individualized Treatment of Advanced Clear Cell Renal Cell Carcinoma
por: Lin, Enyu, et al.
Publicado: (2021)

Establishment and validation of a novel anoikis-related prognostic signature of clear cell renal cell carcinoma
por: Liu, Yankuo, et al.
Publicado: (2023)

Tumor-Infiltrated CD8+ T Cell 10-Gene Signature Related to Clear Cell Renal Cell Carcinoma Prognosis
por: Wang, Jie, et al.
Publicado: (2022)

Identification and Verification of m(7)G Modification Patterns and Characterization of Tumor Microenvironment Infiltration via Multi-Omics Analysis in Clear Cell Renal Cell Carcinoma
por: Dong, Kai, et al.
Publicado: (2022)

Effects of shikonin on the development of ovarian follicles and female germline stem cells
por: Ma, Shu-Xin, et al.
Publicado: (2021)

Overexpression of DBT suppresses the aggressiveness of renal clear cell carcinoma and correlates with immune infiltration
por: Zhang, Chiyu, et al.
Publicado: (2023)

Robust Prediction of Prognosis and Immunotherapeutic Response for Clear Cell Renal Cell Carcinoma Through Deep Learning Algorithm
por: Chen, Siteng, et al.
Publicado: (2022)

OIP5 Is a Novel Prognostic Biomarker in Clear Cell Renal Cell Cancer Correlating With Immune Infiltrates
por: Gong, Mancheng, et al.
Publicado: (2022)

Multi-Omics Analysis of the Prognosis and Biological Function for TRPV Channel Family in Clear Cell Renal Cell Carcinoma
por: Jiang, Yuxiong, et al.
Publicado: (2022)

CD8(+) T Cell-Based Molecular Classification With Heterogeneous Immunogenomic Landscapes and Clinical Significance of Clear Cell Renal Cell Carcinoma
por: Wu, Xiangkun, et al.
Publicado: (2021)

Identification of berberine as a potential therapeutic strategy for kidney clear cell carcinoma and COVID-19 based on analysis of large-scale datasets
por: Zheng, Zhihua, et al.
Publicado: (2023)

Tumor-Infiltrating T Cells From Clear Cell Renal Cell Carcinoma Patients Recognize Neoepitopes Derived From Point and Frameshift Mutations
por: Hansen, Ulla Kring, et al.
Publicado: (2020)

Crosstalk Between Metabolism and Immune Activity Reveals Four Subtypes With Therapeutic Implications in Clear Cell Renal Cell Carcinoma
por: Wang, Yi, et al.
Publicado: (2022)

Comprehensive investigation into cuproptosis in the characterization of clinical features, molecular characteristics, and immune situations of clear cell renal cell carcinoma
por: Wang, Bao, et al.
Publicado: (2022)

Development of a polyamine gene expression score for predicting prognosis and treatment response in clear cell renal cell carcinoma
por: Chen, Mei, et al.
Publicado: (2022)

Wiskott-Aldrich syndrome gene as a prognostic biomarker correlated with immune infiltrates in clear cell renal cell carcinoma
por: Ding, Guixin, et al.
Publicado: (2023)

Integrated analysis to identify the prognostic and immunotherapeutic roles of coagulation-associated gene signature in clear cell renal cell carcinoma
por: Yin, Guicao, et al.
Publicado: (2023)

Characterization of papillary and clear cell renal cell carcinoma through imaging mass cytometry reveals distinct immunologic profiles
por: Govindarajan, Ameish, et al.
Publicado: (2023)

Synthesis of Novel Shikonin Derivatives and Pharmacological Effects of Cyclopropylacetylshikonin on Melanoma Cells
por: Durchschein, Christin, et al.
Publicado: (2018)

Identification of a Novel Stem Cell Subtype for Clear Cell Renal Cell Carcinoma Based on Stem Cell Gene Profiling
por: Wang, Hongzhi, et al.
Publicado: (2021)

Early Response Assessment in Advanced Stage Melanoma Treated with Combination Ipilimumab/Nivolumab
por: Ma, Vincent T., et al.
Publicado: (2022)

Integrated single-cell and bulk characterization of cuproptosis key regulator PDHB and association with tumor microenvironment infiltration in clear cell renal cell carcinoma
por: Wu, Jiajin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_k89rhuv1rg0mu6ogvhbm2soelh